Despite much attention being focused on BRAF mutant melanoma, NRAS was the first melanoma oncogene to be identified12, and mutations in NRAS, KRAS and HRAS are present in about 20, 2 and 1% of all melanomas, respectively13. The gene discussed is BRAF; the disease is melanoma.